Comparison of the pharmacokinetics of verapamil in the pregnant and non-pregnant rabbit: Study of maternal and foetal tissue levels

Xenobiotica

Volumn 30, Issue 1, 2000, Pages 93-102

  Solans, C ^a   Bregante, M A ^a   Aramayona, J J ^a   Frailedagger, L J ^a   Garcia, M A ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; VERAPAMIL;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; FEMALE; FETUS; HEART; HUMAN EXPERIMENT; KIDNEY; LIVER; NONHUMAN; NORMAL HUMAN; PLACENTAL TRANSFER; PREGNANCY; RABBIT; SPLEEN; UTERUS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0033954434     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982500237857     Document Type: Article

References (26)

1. Bai, S. A., Lankford, S. M. and Johnson, L. M., 1993, Pharmacokinetics of the enantiomers of verapamil in the dog. Chirality, 5, 436-442.
2. Byerly, W. G., Hartmann, A., Faster, D. E. and Tannenbaun, A. K., 1991, Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia. Annals of Emergency Medicine, 20, 552-554.
3. Fort, D. J. S., Lewis, M. J. and Luscombe, D. K., 1992, Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers. British Journal of Clinical Pharmacokinetics, 33, 623-627.
4. Fraile, L. J., 1996, Paso transplacentario y modificaciones en la cinética del diltiazem durante la gestación y la ontogénesis en el conejo. Tesis doctoral, University of Zaragoza.
5. Garcia, M. A., Aramayona, J. J., Bregante, M. A., Fraile, L. and Solans, C., 1997, Simultaneous determination of verapamil and norverapamil in biological samples by high performance liquid chromatography using UV detection. Journal of Chromatography B, 693, 377-382.
6. Giacomini, J. C., Nelson, W. L., Theodore, L., Wong, F. M., Rood, D. and Giacomini, K. M., 1985, The pharmacokinetics and pharmacodynamics of D-and D-L,verapamil in rabbits. Journal of Cardiovascular Pharmacology, 7, 469-475.
7. Gillespie, M. N., Felder, T. B., Blanford, S. L., Reinsel, C. N. and Kostenbauer, H. B., 1984, Pulmonary disposition and pharmacodynamics of verapamil. Journal of Cardiovascular Pharmacology, 6, 802-807.
8. Hamann, S. R., Blouin, R. A. and McAllister, R. G., 1984, Clinical pharmacokinetics of verapamil. Clinical Pharmacokinetics, 9, 26-41.
9. Hamann, S. R., Todd, G. D. and McAllister, R. G., 1983, The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog. Pharmacology, 27, 1-8.
10. Hildebrandt, R., Weitzel, H., Warnke, K. and Gundert-Remy, U., 1993, Pharmacokinetics of fenoterol in pregnant and nonpregnant women. European Journal of Clinical Pharmacology, 45, 275-277.
11. Ito, S., Magee, L. and Smallhorn, J., 1994, Drug therapy for fetal arrhythmias. Clinica Perinatologica, 21, 543-572.
12. Jeffries, W. S. and Bochner, F., 1988, The effect of pregnancy on drug pharmacokinetics. Medical Journal of Australia, 149, 675-677.
13. Krauer, B. and Krauer, F., 1983, Drug kinetics in pregnancy. In M. Gibaldi and L. Prescott (eds), Handbook of Clinical Pharmacokinetics (Balgowlah: ADIS Health Science Press), pp. 1-17.
14. Loebstein, R., Laikin, A. and Koren, G., 1997, Pharmacokinetic changes during pregnancy and their clinical relevance. Clinical Pharmacokinetics, 33, 328-343.
15. Manitpisitkul, P. and Chiou, W. L., 1993, Intravenous verapamil kinetic in rats: marked arteriovenous concentration difference and comparison with humans. Biopharmaceutics and Drug Disposition, 14, 555-566.
16. McTavish, D. and Sorkin, E. M., 1989, Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. Drugs, 38, 19-76.
17. Mitani, G. M., Steinberg, I., Lien, E., Harrison, C. and Elkayan, U., 1987, The pharmacokinetics of antiarrythmic agents in pregnancy and lactation. Clinical Pharmacokinetics, 12, 253-291.
18. Murray, L. and Seger, D., 1994, Drug therapy during pregnancy and lactation. Emergency Medical Clinical North America, 12, 129-149.
19. O'Hare, M. F., Kinney, C. D., Murnaghan, G. A. and McDevitt, D. G., 1984, Pharmacokinetics of propranolol during pregnancy. European Journal of Clinical Pharmacology, 27, 583-587.
20. Orlandi, C., Marlettini, M. G., Cassani, A., Trabatti, M., Agostini, D., Salomone, T. and Testoni, N., 1986, Treatment of hypertension during pregnancy with the calcium antagonist verapamil. Current Therapeutics Research Clinical and Experimental, 39, 884-893.
21. Szymanski, W., Skublicki, S., Jankowski, A. and Kotzbach, R., 1992, Pharmacokinetic investigations of verapamil used an a concomitant drug in treatment of premature labor. Ginecologica. Polska, 63, 166-171.
22. Ward, R. M., 1992, Maternal drug therapy for fetal disorders. Seminary Perinatology, 16, 12-20.
23. Wilson, A. G. E., Pickett, R. D., Eling, T. E. and Anderson, M. W., 1979, Studies on the persistence of basic amines in the rabbit lung. Drug Metabolism and Disposition, 76, 420-424.
24. Witter, F. R., 1993, Clinical pharmacokinetics in the treatment of rheumatoid arthritis in pregnancy. Clinical Pharmacokinetics, 25, 444-449.
25. Wolff, F., Breuker, K. H., Schlensker, K. H. and Bolte, A., 1980, Prenatal diagnosis and therapy of fetal heart rate anomalies: with a contribution on the placental transfer of verapamil. Journal of Perinatal Medicine, 8, 203-208.
26. Yamaoka, K., Nakagawa, T. and Uno, T., 1978, Application of the Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175.